Second Sight Medical (EYES) Reports Q2 Loss of $0.11
Second Sight Medical (NASDAQ: EYES) reported Q2 EPS of ($0.11), versus ($0.12) reported last year. Revenue for the quarter came in at $1.9 million, versus $2.2 million reported last year.
For earnings history and earnings-related data on Second Sight Medical (EYES) click here.